We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$23.5B
AUM Growth
+$825M
(+3.6%)
Cap. Flow
+$352M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
76
New
13
Increased
23
Reduced
16
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$785M |
| 2 |
T-Mobile US
TMUS
|
+$463M |
| 3 |
Mastercard
MA
|
+$428M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$352M |
| 5 |
Microsoft
MSFT
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$678M |
| 2 |
Elevance Health
ELV
|
+$674M |
| 3 |
AET
Aetna Inc
AET
|
+$333M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$279M |
| 5 |
TransDigm Group
TDG
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.63% |
| 2 | Healthcare | 21.02% |
| 3 | Consumer Discretionary | 15.15% |
| 4 | Energy | 12.34% |
| 5 | Technology | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Editas Medicine
EDIT
$442M
| $41.7M | 0.18% |
1,709,401
-426,122
| -20% | -$14.4M |
|
52
Centene
CNC
$32.5B
| $34.9M | 0.15% |
+978,602
| New | +$30.7M |
|
|
MR
53
DELISTED
Montage Resources Corporation Common Stock
MR
| $24.6M | 0.1% |
491,229
+473,162
| +2,619% | +$19.5M |
|
|
SC
54
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $10.9M | 0.05% |
+1,054,384
| New | +$12.2M |
|
|
CLD
55
DELISTED
Cloud Peak Energy Inc
CLD
| $6.04M | 0.03% |
+2,930,781
| New | +$5.99M |
|
56
BioMarin Pharmaceuticals
BMRN
$12.4B
| – | – |
-602,116
| Closed | -$49.7M |
|
57
Chubb
CB
$135B
| – | – |
-995,044
| Closed | -$119M |
|
58
Crown Castle
CCI
$32.2B
| – | – |
-536,396
| Closed | -$46.4M |
|
59
DexCom
DXCM
$32B
| – | – |
-1,945,956
| Closed | -$33M |
|
|
60
Elevance Health
ELV
$85.5B
| – | – |
-4,849,229
| Closed | -$674M |
|
61
Home Depot
HD
$355B
| – | – |
-491,555
| Closed | -$65.6M |
|
62
Hilton Worldwide
HLT
$71.5B
| – | – |
-437,629
| Closed | -$29.6M |
|
63
Labcorp
LH
$25.9B
| – | – |
-783,428
| Closed | -$78.8M |
|
64
Cheniere Energy
LNG
$52.9B
| – | – |
-1,458,025
| Closed | -$49.3M |
|
65
LyondellBasell Industries
LYB
$19.2B
| – | – |
-303,852
| Closed | -$26M |
|
66
MetLife
MET
$62.1B
| – | – |
-2,875,193
| Closed | -$113M |
|
67
Pfizer
PFE
$153B
| – | – |
-1,177,942
| Closed | -$33.1M |
|
68
Progressive
PGR
$125B
| – | – |
-1,602,234
| Closed | -$56.3M |
|
69
Prudential Financial
PRU
$41.8B
| – | – |
-2,258,442
| Closed | -$163M |
|
|
70
TransDigm Group
TDG
$67.7B
| – | – |
-1,101,310
| Closed | -$243M |
|
71
Universal Health Services
UHS
$10.5B
| – | – |
-429,887
| Closed | -$53.6M |
|
|
ENDP
72
DELISTED
Endo International plc
ENDP
| – | – |
-4,468,744
| Closed | -$126M |
|
|
KSU
73
DELISTED
Kansas City Southern
KSU
| – | – |
-286,589
| Closed | -$24.5M |
|
|
AKRX
74
DELISTED
Akorn Inc
AKRX
| – | – |
-2,081,398
| Closed | -$49M |
|
|
JAH
75
DELISTED
JARDEN CORPORATION
JAH
| – | – |
-1,406,492
| Closed | -$82.9M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2016 Portfolio in Review
As of Q2 2016, Viking Global Investors held 76 positions worth $23.5B, up 3.6% from $22.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Viking Global Investors's Q2 2016 filing shows 13 new, 23 increased, 16 reduced and 21 closed positions. Its largest new stake was Microsoft: 5,633,782 shares worth $288M. The largest sale was Allergan plc, an estimated $678M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Viking Global Investors's largest Q2 2016 buy was Microsoft: 5,633,782 shares worth $288M.
- Viking Global Investors added most to Biogen in Q2 2016, an estimated $785M increase.
- Viking Global Investors's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $678M.
- Viking Global Investors fully exited Elevance Health in Q2 2016, selling an estimated $674M.
- Viking Global Investors's ten largest holdings make up 55% of its $23.5B portfolio in Q2 2016.
- Viking Global Investors opened 13 new positions and closed 21 in Q2 2016.
- Viking Global Investors's portfolio value rose 3.6% quarter-over-quarter to $23.5B.
Based on Viking Global Investors's 13F filing for Q2 2016, filed 15 Aug 2016.